SCHEMBL6220171

SCHEMBL6220171

CCOC(=O)N(CC)Cc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
LMNA P02545 3/20 0.64
HSD17B10 Q99714 2/20 0.60
POLB P06746 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
TRPM8 Q7Z2W7 1/20 0.58
TSHR P16473 2/20 0.58
MAPK1 P28482 2/20 0.58
NPC1 O15118 3/20 0.56
ALOX15 P16050 1/20 0.56
TSPO P30536 1/20 0.52
MGLL Q99685 1/20 0.51
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
RAB9A P51151 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9278775 0.93 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL13687190 0.88 LMNA (0.62) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL11429803 0.87 LMNA (0.57) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL10816551 0.87 ALDH1A1 (0.57) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL18154278 0.85 ALDH1A1 (0.56) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL15762363 0.84 LMNA (0.66) ALDH1A1LMNAHSD17B10TRPM8TSHR
SCHEMBL13434152 0.84 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL11022276 0.84 ALDH1A1 (0.55) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL7600830 0.83 MEN1 (0.54) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL11766317 0.83 ALDH1A1 (0.45) ALDH1A1LMNAHSD17B10POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575947-A1 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES Amgen Inc. (US) 2005-09-21 EP claimed
WO-2004060890-A1 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES AMGEN INC. (US) 2004-07-22 WO claimed
EP-1575947-A1 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES Amgen Inc. (US) 2005-09-21 EP disclosed
WO-2004060890-A1 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES AMGEN INC. (US) 2004-07-22 WO disclosed
CN-1300730-A Process for preparing aminoformate compounds with CO2 instead of severely toxic optical gas SHANGHAI INST ORGANIC CHEM (CN) 2001-06-27 CN disclosed
CN-1224001-A Process for preparation of carbonates and polycarbonates MONSANTO CO (US) 1999-07-28 CN disclosed